Exploration of antihyperglycaemic potential of the siddha formulation Vallarai choorana tablet by In vitro α-amylase and α-glucosidase enzyme inhibition assay

Diabetes mellitus is a chronic metabolic disease that can be suspected or recognized clinically by the onset of one or more of the characteristic symptoms such as polyuria, polydipsia, polyphagia, and unsolved weight loss. As per the statistics established in the year 2013, the prevalence of diabete...

Full description

Saved in:
Bibliographic Details
Published inNeuroQuantology Vol. 20; no. 19; p. 329
Main Authors Meena, S, Iyswarya, S, Visweswaran, S, Muthukumar, N J, Tamilselvi, S
Format Journal Article
LanguageEnglish
Published Bornova Izmir NeuroQuantology 01.01.2022
Subjects
Amylases
Antidiabetics
Diabetes
Diabetes mellitus
Diabetic neuropathy
Enzymes
Glucose
Glucosidase
Hypoglycemia
Insulin
Metabolic disorders
Metabolism
Pharmaceuticals
Polysaccharides
Signs and symptoms
Weight loss
Online AccessGet full text

Cover

More Information
Summary:Diabetes mellitus is a chronic metabolic disease that can be suspected or recognized clinically by the onset of one or more of the characteristic symptoms such as polyuria, polydipsia, polyphagia, and unsolved weight loss. As per the statistics established in the year 2013, the prevalence of diabetes in India was 9.1%, which was just slightly higher than the global average of 8.3%. On the other hand, because of the country's enormous population, India has the second-largest diabetic population in the world, behind China. Pancreatic enzymes alpha-amylase and alpha-glucosidase catalyse the breakdown of polysaccharides into simpler sugars.
ISSN:1303-5150
DOI:10.48047/nq.2022.20.19.NQ99028